Trial Profile
Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve) - Observations from Canada
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms OBSErve
- Sponsors GlaxoSmithKline; GSK
- 29 Mar 2018 New trial record